The nonproprietary name for this product is voretigene neparvovec. The suffix '-neparvovec' is proposed in accordance with the Agency's guidance on Nonproprietary Naming of Biological Products. It consists of 'ne' for the transgene (RPE65), 'parvo' for the vector (parvovirus/AAV), and 'vec' for vector.